2023-05-15T11:42:56-05:00 2022-06-30 814234542 BPM LLP 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 940251021 990 2021-07-01 453266802 CANCER COMMONS CANC 6502894044 650 CASTRO STREET SUITE 120 PMB52 MOUNTAIN VIEW CA 94041 SHELLEY FRISBIE CHIEF FINANCIAL OFFICER 6502894044 2023-05-11 1 SHELLEY FRISBIE 999009999 TAMARA L MCINERNEY P00011797 6508556800 2023-05-11 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z JAY M TENENBAUM 650 CASTRO STREET SUITE 120 PMB522 MOUNTAIN VIEW CA 94041 1655358 0 X WWW.CANCERCOMMONS.ORG X 2011 CA CANCER COMMONS BRINGS TOGETHER A TEAM OF EXPERTS, WHO COMBINE COMPASSION WITH SCIENTIFIC KNOWLEDGE TO HELP PATIENTS UNDERSTAND THEIR DISEASE AND ACCESS THEIR BEST TREATMENT OPTIONS. EACH PATIENT IS CONNECTED TO A TEAM, CONSISTING OF NURSE NAVIGATORS, PHD SCIENTISTS, PHYSICIANS, AND NATIONAL EXPERTS, WHO, REVIEW THE PATIENT'S MEDICAL HISTORY, RESEARCH ADDITIONAL TESTING THAT COULD IMPACT THE PATIENT'S TREATMENT PLAN, IDENTIFY CLINICAL TRIAL OPTIONS AVAILABLE FOR THE PATIENT, INVESTIGATE ACCESS TO NEW OFF-LABEL TREATMENTS, AS WELL AS OBTAIN KEY INSIGHTS FROM CANCER EXPERTS THROUGH VIRTUAL TUMOR BOARDS. CANCER COMMONS' GOAL IS TO EQUIP PATIENTS WITH THE KNOWLEDGE THEY NEED TO BE ABLE TO CHOOSE THEIR BEST PLAN OF ACTION AT NO COST TO THE PATIENT. 7 7 10 2 0 0 1733265 1629264 0 25733 0 361 6280 0 1739545 1655358 0 43680 0 0 1157737 1139490 0 0 177099 540278 453010 1698015 1636180 41530 19178 829247 832926 78325 62826 750922 770100 X CANCER COMMONS BRINGS TOGETHER A TEAM OF EXPERTS, WHO COMBINE COMPASSION WITH SCIENTIFIC KNOWLEDGE TO HELP PATIENTS UNDERSTAND THEIR DISEASE AND ACCESS THEIR BEST TREATMENT OPTIONS. 0 0 1312108 43680 25733 SEE SCHEDULE O 1312108 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 15 0 1 10 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 7 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X MARTHA DEHNOW 6505303636 650 CASTRO STREET SUITE 120 PMB522 MOUNTAIN VIEW CA 94041 X JAY M TENENBAUM PRESIDENT 20.00 X X 0 0 0 LAURENCE MARTON BOARD MEMBER 1.00 X 0 0 0 GLADYS MONROY BOARD MEMBER 1.00 X 0 0 0 PAUL BILLINGS BOARD MEMBER (FROM 11/25/21) 1.00 X 0 0 0 DAVE DALY BOARD MEMBER (FROM 11/25/21) 1.00 X 0 0 0 VERN NORVIEL BOARD MEMBER 1.00 X 0 0 0 ED STAREN BOARD MEMBER 1.00 X 0 0 0 MARK JACOBSTEIN BOARD MEMBER (TO 2/27/22) 1.00 X 0 0 0 SHELLEY FRISBIE CFO 40.00 X 135000 0 0 MASAKO DUBOIS SECRETARY 40.00 X 28013 0 6972 EMILYA SHTIVELMAN CHIEF SCIENTIST 33.00 X 134749 0 2270 LOLA RAHIB SCIENTIST 40.00 X 140000 0 9027 MATTHEW WARNER SCIENTIST 40.00 X 134583 0 214 572345 0 18483 4 0 0 0 THE SHELLARD GROUP 1325 HOWARD AVE 944 BURLINGAME CA 94010 GENERAL & ADMINISTRATION, ACCOUNTING 135000 1 1629264 10593 1629264 PROGRAM SERVICE FEES 900099 25733 25733 25733 361 361 1655358 25733 0 361 X 43680 43680 170000 110500 21250 38250 822276 745742 40231 36303 82532 56217 13874 12441 64682 58826 2969 2887 38452 10036 16458 11958 358945 268169 33787 56989 32742 11710 6185 14847 3060 -361 128 3293 1705 1705 OTHER EXPENSES 18106 7589 10386 131 1636180 1312108 146973 177099 666211 419572 134000 400000 1278 24053 11354 6828 6828 1705 0 2000 2000 829247 832926 78325 62826 78325 62826 X 650922 590204 100000 179896 750922 770100 829247 832926 19178 0 X X 0 1 X 1 0 X 1622936 1802396 2103518 1733265 1629264 8891379 1622936 1802396 2103518 1733265 1629264 8891379 4010776 4880603 361 361 2500 868 6329 9697 8901437 25733 0.54830 0.46770 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 6828 6828 0 0 X 1755633 100275 100275 1655358 0 1655358 1736455 100275 100275 1636180 0 1636180 PART X, LINE 2: ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA PROVIDE ACCOUNTING AND DISCLOSURE GUIDANCE ABOUT POSITIONS TAKEN BY AN ORGANIZATION IN ITS TAX RETURNS THAT MIGHT BE UNCERTAIN. MANAGEMENT HAS CONSIDERED ITS TAX POSITIONS AND BELIEVES THAT ALL OF THE POSITIONS TAKEN BY THE ORGANIZATION IN ITS FEDERAL AND STATE EXEMPT ORGANIZATION TAX RETURNS ARE MORE-LIKELY-THAN-NOT TO BE SUSTAINED UPON EXAMINATION. EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES PROGRAM SERVICES 11728 0 0 0 0 0 0 11728 0 11728 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 THE WARREN ALPERT MEDICAL SCHOOL OF BROWN RHODE ISLAND HOSPITAL 167 POINT STREET BOX 42 PROVIDENCE RI 02903 050258954 501C3 21840 0 VIRTUAL TUMOR BOARDS BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVENUE BR-259 BOSTON MA 02215 042103881 501C3 21840 0 VIRTUAL TUMOR BOARDS 2 0 FORM 990, PART III, LINE 4A CANCER COMMONS BRINGS TOGETHER A TEAM OF NURSE NAVIGATOR, PHD SCIENTISTS, PHYSICIANS, AND NATIONAL EXPERTS, WHO COMBINE COMPASSION WITH DEEP SCIENTIFIC KNOWLEDGE TO HELP PATIENTS UNDERSTAND THEIR DISEASE AND ACCESS THEIR BEST TREATMENT OPTIONS. CANCER TYPES - CANCER COMMONS ASSISTS PATIENTS WITH VARIOUS CANCER TYPES, PARTICULARLY THOSE THAT ARE DIFFICULT TO TREAT. THESE INCLUDE, BUT ARE NOT LIMITED TO, BRAIN, PANCREATIC, OVARIAN, COLORECTAL, BREAST, LUNG, AND BLADDAR CANCERS. ACCOMPLISHMENTS ACROSS ALL CANCER TYPES INCLUDE: FURTHER ENHANCEMENT OF THE REGISTRATION PROCESS WHICH INCLUDES A NURSE NAVIGATOR TO ASSIST PATIENTS AND CAREGIVERS COLLECT MEDICAL RECORDS AND IDENTIFY THEIR SPECIFIC NEEDS INCLUDING GOALS OF TREATMENT. INCREASED THE LIBRARY OF TREATMENT OPTIONS FOR CANCER PATIENTS, BY CANCER TYPE, BASED ON THE LATEST CLINICAL AND SCIENTIFIC DISCOVERIES. EXPANDED THE VIRTUAL TUMOR BOARDS ("VTB") PROGRAM TO INCLUDE PANCREATIC AS WELL AS BRAIN PATIENTS. VTB IS A NETWORK OF NATIONAL EXPERTS INCLUDING ONCOLOGISTS, RADIATION ONCOLOGISTS, SURGEONS, AND CLINICAL SCIENTISTS, ORGANIZED BY CANCER TYPES. THESE VTBS REVIEW INDIVIDUAL CANCER PATIENTS' CASES AND PROVIDE BEST-IN-CLASS, DETAILED TREATMENT OPTIONS REPORTS TO SHARE WITH THE PATIENTS' ONCOLOGISTS AND MEDICAL TEAMS. A NEWLY REVISED BRAND AND WEBSITE PLATFORM LAUNCED ON JULY 31, 2021, WHICH HELPED SUPPORT THE TREMENDOUS INFLUX OF NEW PATIENTS (74.5% INCREASE IN NEW PATIENTS OVER PREVIOUS FISCAL YEAR). CONTINUED POSTING AND PUBLISHING OF AN EDUCATIONAL SERIES OF ARTICLES TO INFORM PATIENTS OF THE LATEST ADVANCEMENTS IN THE FIRST OF PRECISION TECHNOLOGY. PARTNERSHIP WITH XCURES - PATIENTS ARE INVITED TO ENROLL IN A "PERPETUAL CLINICAL TRIAL" THAT CANCER COMMONS IS RUNNING IN PARTNERSHIP WITH TECHNOLOGY PARTNER XCURES. THIS PERPETUAL TRIAL IS OPEN TO PATIENTS RECEIVING CARE IN THE U.S., WHICH ALLOWS THE ORGANIZATION TO LEARN FROM EACH PATIENT TO HELP SIMILAR PATIENTS, AND EVENTUALLY, ALL FUTURE PATIENTS. XCURES CURRENTLY HAS 1,168 PATIENTS ENROLLED IN THE PROJECT, OF WHICH 716 WERE ADDED DURING THE YEAR ENDED JUNE 30, 2021. OTHER PARTNERSHIPS - CANCER COMMONS HAS PARTNERSHIPS WITH OTHER ORGANIZATION AND INSTITUTIONS WHO SHARE THE CANCER COMMONS PATIENT-CENTRIC PHILOSOPHY. THESE ORGANIZATIONS REFER PATIENTS WITH CHALLENGING CASES OR OFFER THEIR SERVICES TO CANCER COMMONS' PATIENTS. THE MOST ACTIVE PARTNERS ARE THE PANCREATIC CANCER ACTION NETWORK (PANCAN) AND THE MUSELLA FOUNDATION FOR BRAIN TUMOR RESEARCH & INFORMATION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS GIVEN TO THE GOVERNING BODY BEFORE THE RETURN IS FILED. THEY REVIEW AND CAN REQUEST CHANGES AT THIS TIME. FORM 990, PART VI, SECTION B, LINE 12C THE OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE REQUIRED TO REVIEW AND SIGN THE WRITTEN CONFLICT OF INTEREST POLICY ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS PERFORMS ALL INTERVIEWS SPECIFIC TO TOP KEY POSITIONS WHICH IS THEN FORWARDED TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 MADE AVAILABLE UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1A: SHELLEY FRISBIE'S COMPENSATION STATED ON PART VII, SECTION A, LINE 1A WAS ALSO INCLUDED AS A PAYMENT TO AN INDEPENDENT CONTRACTOR ON PART VII, PART B, LINE 1. FORM 990, PART IX, LINE 11G CONSULTING FEES: PROGRAM SERVICE EXPENSES 115,415. MANAGEMENT AND GENERAL EXPENSES 33,787. FUNDRAISING EXPENSES 56,989. TOTAL EXPENSES 206,191. SCIENTISTS AND OTHER MEDICAL PROFESSIONALS: PROGRAM SERVICE EXPENSES 152,754. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 152,754. FORM 990, PART XII, LINE 2C THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.